Sign In to Follow Application
View All Documents & Correspondence

Process For The Purification Of Polyaminocarboxylates

Abstract: The present invention relates to an improved process for the purification of polyaminocarboxylates such as DOTA, DTPA, D03A-butrol, BOPTA.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
25 November 2011
Publication Number
19/2014
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2018-10-22
Renewal Date

Applicants

BIOPHORE INDIA PHARMACEUTICALS PVT. LTD.
PLOT #193, PREMISES #5-35/50, PRASHANT NAGAR, KUKATPALLY, HYDERABAD - 500 072

Inventors

1. JAGADEESH BABU RANGISETTY
FLAT #401, PLOT #30, SRINAGAR COLONY, HYDERABAD
2. MANIK REDDY PULLAGURLA
22-70 EENADU COLONY, KUKATPALLY, HYDERABAD
3. RAJESH BHUDETI
5-5-35/54/1, PRASHANT NAGAR, KUKATPALLY, HYDERABAD

Specification

PROCESS FOR THE PURIFICATION OF POLYAMINOCARBOXYLATES

Background

The invention relates to the purification of polyaminocarboxylate chelating agents which can be used as MRI contrast agents. Polyaminocarboxylates are part of several drugs which include gadoteric acid, gadobutrol, gadobenic acid, gadopentetate, gadoversetamide, gadodiamide. The key ingredient to all the gadolinium based drugs is the chelate to which the gadolinium binds. Having a highly pure chelate free of any salts and metals is the basis for the preparation of the pure gadolinium based MRI agents.

Some of the chelates include 1,4,7,1O-tetraazocyclododecane-, 1,4,7,10-tetraacetic acid (DOTA) for gadoteric acid, Pentetic acid (DTPA) for gadopentetate, BOPTA for gadobenic acid, 10-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-tris(carboxymethyl)-1,4,7,10-tetraazocyclododecane (D03A-butrol) for gadobutrol.

State of the art

Some of the chelates reported in the literature involve complex and expensive purification methods which involve resins of various kinds.

US5922862 describes a procedure for the purification of DOTA and other cyclen substituted derivatives. It describes a procedure for the removal of inorganic salts by elution of the crude product dissolved in water over PVP resin.

Inorg. Chem. 1980, 19, 1319 describes a procedure for the purification of DOTA using Dowex 50W-X4 resin.

Inorg. Chem. 1997, 36, 6086 describes a procedure for the purification of D03A-butrol with IR120H+ resin to remove salts.

Likewise several other resins are reported for the purification of the chelates to remove inorganic salts.

The resin methods involved are expensive and some of the chelates bind to the resins, which then require washing with ammonia solution or formic acid solutions. Removal of ammonium ions becomes particularly difficult as the ligand forms ammonium salts.

The manufacturing of the chelates becomes difficult when large ion-exchange columns are required at commercial scale manufacturing. Since most of the chelates have high water solubility the distillation of water becomes time consuming and also leads to potential degradation products.

Summary of the invention

One of the objects of the invention was to provide a process for the preparation of the chelates in the pure form without the presence of impurities such as inorganic salts and other ions such as chloride, bromide, sulphate or the like.

Yet another object of the invention was to develop a process with low cycle time, which is commercially viable, inexpensive and which utilizes none or minimal amount of resin.

Detailed description of the invention

The purification procedure of chelates without ion-exchange column purifications are particularly advantageous as they are less time consuming and are rather inexpensive.

It has now surprisingly been found that polyaminocarboxylate compounds when isolated under highly acidic conditions preferably below 0.75 are isolated as their acid salts and upon purification of these salts by recrystallization from water or water solvent mixtures result in polyaminocarboxylate with a content of any inorganic salts or ions such as sodium, potassium or the like below 200 ppm. The acid employed for the salt formation can be hydrochloric acid, hydrobromic acid, sulfuric acid and the like. The acid is preferably hydrochloric acid and the salt isolated is as hydrochloride salt.

The water solvent mixtures employed are water/acetone, water/ethanol, water/methanol or the like to obtain a product free of undesired chloride or bromide ions, which have very stringent specifications.

The salt thus obtained is dissolved in water and is then adjusted to the desired pH either with an aqueous basic solution or alternatively a resin. It is noteworthy to mention here that the amount of resin employed is minimal and is used to adjust the pH of the solution about 1.5 - 3.0, thereby eliminating the chance for any additional inorganic salt formation. As the resin employed is in minimal amounts the process does not suffer from the drawbacks of the prior art. The pH is preferably adjusted with a basic anionic resin.

The resins that are employed in the current process are resin in the hydroxide form such as Amberlyst A26 OH resin and the like. The bases that can be employed for the pH adjustment are potassium hydroxide, sodium hydroxide, ammonium hydroxide, triethyl amine or the like.

An example of the process schematics is shown below for DOTA. The example described for DOTA is not limiting and a similar purification process can be applied to any polyaminocarboxylate.

The following examples describe the process in greater detail. Example 1: Synthesis of DOTA
Charge 100 ml of water and 100 g cyclen HCI to a flask. Cool the reaction mass to 0-10 °C and adjust the pH of the solution to 10-10.5 with sodium hydroxide. Charge chloroacetic acid to the reaction with continuous pH adjustment to 10-10.5 with sodium hydroxide solution. Slowly raise the reaction to 70-75 °C and maintain until the completion of reaction. Cool the reaction mass and adjust the pH of the reaction to below 0.75 with cone. HCI and filter the solid separated which is DOTA hydrochloride. Recrystallize the solid from water and check the content of sulfated ash to be below 0.10%. The solid is then dissolved in 800 ml water and the pH of the solution adjusted to around 2.5 to 3.0 with amberlyst A26 OH resin to obtain a chelate free of hydrochloride salt. The mass is then filtered, and the filtrate obtained is distilled to 200-300 ml water and the solid is precipitated by adding acetone. The solid is filtered and dried to give the title product with desired purity having sulfated ash content below 0.1% and the sodium and chloride content below 200 ppm

Example 2: Synthesis of BOPTA
To a flask were charged 100 ml of water and 50 g of N-[2-[(2-aminoethyl)amino]ethyl]-0-(phenylmethyl)serine. Cool the reaction mass to 0-10 °C and adjust the pH of the solution to 10.5-11.5 with sodium hydroxide solution. Charge chloroacetic acid to the reaction with continuous pH adjustment to 10.5-11.5 with sodium hydroxide solution. Slowly raise the reaction temperature to 70-75 °C and maintain until the completion of reaction. Cool the reaction mass and adjust the pH of the reaction to below 0.75 with Cone. HCI and charge acetone. Filter the solid separated which is BOPTA hydrochloride salt. Recrystallize the solid from water and check the sulfated ash content to be below 0.10%. The solid is then dissolved in 800 ml water and the pH of the solution adjusted to around 2.0 with amberlyst A26 OH resin. The mass is then filtered and the filtrate is distilled to 200-300 ml water and the solid is precipitated by adding acetone. The solid thus obtained is filtered and dried to give the product with desired purity having sulfated ash below 0.1%.

Claims:

1. A process for the purification of polyaminocarboxylates like DOTA,
DTPA, D03A-butrol, BOPTA which comprises:

a) treating an aqueous solution polyaminocarboxylate with an inorganic acid, wherein the pH of the solution is below 0.75

b) recrystallizing the precipitated polyaminocarboxylate acid salt in water or water solvent mixtures

c) treating the aqueous solution of polyaminocarboxylate acid salt with a resin or a basic solution to maintain pH at 1.5 to 3.0

d) isolating the pure polyaminocarboxylate chelate

2. The process of claim 1 wherein the inorganic acid employed is selected from hydrochloric acid, hydrobromic acid, sulfuric acid

3. The process of claim 1 wherein the polycarboxylate purified is DOTA and the inorganic acid employed is Hydrochloric acid.

4. The process of claim 1 wherein the polycarboxylate purified is BOPTA and the inorganic acid employed is Hydrochloric acid.

5. The process of claim 1 wherein the resin employed is basic anionic resin such as amberlyst A26 OH resin.

6. The process of claim 1 wherein the polyaminocarboxylate isolated contains sodium, potassium, sulfate, chloride, bromide, ammonium salt impurities below 200 ppm.

7. Substantially pure polyaminocarboxylate obtained by the process of claim 1, wherein the sulfated ash is below 0.1% and the ion impurities are below 200 ppm.

Documents

Orders

Section Controller Decision Date

Application Documents

# Name Date
1 4068-CHE-2011 FORM-5 25-11-2011.pdf 2011-11-25
1 4068-CHE-2011-RELEVANT DOCUMENTS [18-08-2021(online)].pdf 2021-08-18
2 4068-CHE-2011 FORM-3 25-11-2011.pdf 2011-11-25
2 4068-CHE-2011-Correspondence_15-02-2021.pdf 2021-02-15
3 4068-CHE-2011-Form 27_License_04-03-2020.pdf 2020-03-04
3 4068-CHE-2011 FORM-2 25-11-2011.pdf 2011-11-25
4 4068-CHE-2011-RELEVANT DOCUMENTS [22-02-2020(online)].pdf 2020-02-22
4 4068-CHE-2011 FORM-1 25-11-2011.pdf 2011-11-25
5 Correspondence by Agent_Form28_14-11-2019.pdf 2019-11-14
5 4068-CHE-2011 DESCRIPTION (PROVISIONAL) 25-11-2011.pdf 2011-11-25
6 4068-CHE-2011-EVIDENCE FOR REGISTRATION UNDER SSI [31-10-2019(online)].pdf 2019-10-31
6 4068-CHE-2011 FORM-13 26-11-2012.pdf 2012-11-26
7 4068-CHE-2011-FORM FOR SMALL ENTITY [31-10-2019(online)].pdf 2019-10-31
7 4068-CHE-2011 CORRESPONDENCE OTHERS 26-11-2012.pdf 2012-11-26
8 4068-CHE-2011-RELEVANT DOCUMENTS [27-03-2019(online)].pdf 2019-03-27
8 4068-CHE-2011 CORRESPONDENCE OTHERS 26-11-2012.pdf 2012-11-26
9 4068-CHE-2011 FORM-5 26-11-2012.pdf 2012-11-26
9 Correspondence by Applicant_Form-13_26-11-2018.pdf 2018-11-26
10 4068-CHE-2011 FORM-3 26-11-2012.pdf 2012-11-26
10 4068-CHE-2011-FORM 13 [16-11-2018(online)].pdf 2018-11-16
11 4068-CHE-2011 FORM-2 26-11-2012.pdf 2012-11-26
11 4068-CHE-2011-IntimationOfGrant22-10-2018.pdf 2018-10-22
12 4068-CHE-2011 FORM-1 26-11-2012.pdf 2012-11-26
12 4068-CHE-2011-PatentCertificate22-10-2018.pdf 2018-10-22
13 4068-CHE-2011 DESCRIPTION (COMPLETE) 26-11-2012.pdf 2012-11-26
13 Abstract_Granted 302326_22-10-2018.pdf 2018-10-22
14 4068-CHE-2011 CLAIMS 26-11-2012.pdf 2012-11-26
14 Claims_Granted 302326_22-10-2018.pdf 2018-10-22
15 4068-CHE-2011 ABSTRACT 26-11-2012.pdf 2012-11-26
15 Description_Granted 302326_22-10-2018.pdf 2018-10-22
16 4068-CHE-2011 FORM-3 10-06-2013.pdf 2013-06-10
16 Marked Up Claims_Granted 302326_22-10-2018.pdf 2018-10-22
17 4068-CHE-2011-Written submissions and relevant documents (MANDATORY) [27-09-2018(online)].pdf 2018-09-27
17 4068-CHE-2011 CORRESPONDENCE OTHERS 10-06-2013.pdf 2013-06-10
18 4068-CHE-2011-HearingNoticeLetter.pdf 2018-09-04
18 MSME CERT. BIOPHORE.pdf 2014-03-07
19 Correspondence by Agent_Form1_09-05-2018.pdf 2018-05-09
19 FORM-28.pdf 2014-03-07
20 4068-CHE-2011-ABSTRACT [24-04-2018(online)].pdf 2018-04-24
20 POA-4068-CHE-2011.pdf 2014-03-28
21 4068-CHE-2011-AMENDED DOCUMENTS [24-04-2018(online)]-1.pdf 2018-04-24
21 FORM-13 [address change of the service].pdf 2014-03-28
22 4068-CHE-2011-AMENDED DOCUMENTS [24-04-2018(online)].pdf 2018-04-24
22 FORM-1.pdf 2014-03-28
23 4068-CHE-2011 FORM-13 04-03-2015.pdf 2015-03-04
23 4068-CHE-2011-Changing Name-Nationality-Address For Service [24-04-2018(online)].pdf 2018-04-24
24 4068-CHE-2011-FER.pdf 2017-10-25
24 4068-CHE-2011-CLAIMS [24-04-2018(online)].pdf 2018-04-24
25 4068-CHE-2011-COMPLETE SPECIFICATION [24-04-2018(online)].pdf 2018-04-24
25 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)].pdf 2018-04-24
26 4068-CHE-2011-CORRESPONDENCE [24-04-2018(online)].pdf 2018-04-24
26 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-2.pdf 2018-04-24
27 4068-CHE-2011-FER_SER_REPLY [24-04-2018(online)].pdf 2018-04-24
27 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-1.pdf 2018-04-24
28 4068-CHE-2011-FORM 13 [24-04-2018(online)].pdf 2018-04-24
28 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-1-1.pdf 2018-04-24
29 4068-CHE-2011-FORM 3 [24-04-2018(online)]-1.pdf 2018-04-24
29 4068-CHE-2011-PETITION UNDER RULE 137 [24-04-2018(online)].pdf 2018-04-24
30 4068-CHE-2011-PETITION UNDER RULE 137 [24-04-2018(online)]-1.pdf 2018-04-24
30 4068-CHE-2011-FORM 3 [24-04-2018(online)]-2.pdf 2018-04-24
31 4068-CHE-2011-FORM 3 [24-04-2018(online)]-3.pdf 2018-04-24
31 4068-CHE-2011-OTHERS [24-04-2018(online)].pdf 2018-04-24
32 4068-CHE-2011-FORM 3 [24-04-2018(online)].pdf 2018-04-24
32 4068-CHE-2011-Information under section 8(2) (MANDATORY) [24-04-2018(online)].pdf 2018-04-24
33 4068-CHE-2011-FORM-26 [24-04-2018(online)].pdf 2018-04-24
34 4068-CHE-2011-FORM 3 [24-04-2018(online)].pdf 2018-04-24
34 4068-CHE-2011-Information under section 8(2) (MANDATORY) [24-04-2018(online)].pdf 2018-04-24
35 4068-CHE-2011-FORM 3 [24-04-2018(online)]-3.pdf 2018-04-24
35 4068-CHE-2011-OTHERS [24-04-2018(online)].pdf 2018-04-24
36 4068-CHE-2011-FORM 3 [24-04-2018(online)]-2.pdf 2018-04-24
36 4068-CHE-2011-PETITION UNDER RULE 137 [24-04-2018(online)]-1.pdf 2018-04-24
37 4068-CHE-2011-FORM 3 [24-04-2018(online)]-1.pdf 2018-04-24
37 4068-CHE-2011-PETITION UNDER RULE 137 [24-04-2018(online)].pdf 2018-04-24
38 4068-CHE-2011-FORM 13 [24-04-2018(online)].pdf 2018-04-24
38 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-1-1.pdf 2018-04-24
39 4068-CHE-2011-FER_SER_REPLY [24-04-2018(online)].pdf 2018-04-24
39 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-1.pdf 2018-04-24
40 4068-CHE-2011-CORRESPONDENCE [24-04-2018(online)].pdf 2018-04-24
40 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)]-2.pdf 2018-04-24
41 4068-CHE-2011-COMPLETE SPECIFICATION [24-04-2018(online)].pdf 2018-04-24
41 4068-CHE-2011-RELEVANT DOCUMENTS [24-04-2018(online)].pdf 2018-04-24
42 4068-CHE-2011-CLAIMS [24-04-2018(online)].pdf 2018-04-24
42 4068-CHE-2011-FER.pdf 2017-10-25
43 4068-CHE-2011 FORM-13 04-03-2015.pdf 2015-03-04
43 4068-CHE-2011-Changing Name-Nationality-Address For Service [24-04-2018(online)].pdf 2018-04-24
44 4068-CHE-2011-AMENDED DOCUMENTS [24-04-2018(online)].pdf 2018-04-24
44 FORM-1.pdf 2014-03-28
45 4068-CHE-2011-AMENDED DOCUMENTS [24-04-2018(online)]-1.pdf 2018-04-24
45 FORM-13 [address change of the service].pdf 2014-03-28
46 POA-4068-CHE-2011.pdf 2014-03-28
46 4068-CHE-2011-ABSTRACT [24-04-2018(online)].pdf 2018-04-24
47 Correspondence by Agent_Form1_09-05-2018.pdf 2018-05-09
47 FORM-28.pdf 2014-03-07
48 4068-CHE-2011-HearingNoticeLetter.pdf 2018-09-04
48 MSME CERT. BIOPHORE.pdf 2014-03-07
49 4068-CHE-2011 CORRESPONDENCE OTHERS 10-06-2013.pdf 2013-06-10
49 4068-CHE-2011-Written submissions and relevant documents (MANDATORY) [27-09-2018(online)].pdf 2018-09-27
50 4068-CHE-2011 FORM-3 10-06-2013.pdf 2013-06-10
50 Marked Up Claims_Granted 302326_22-10-2018.pdf 2018-10-22
51 4068-CHE-2011 ABSTRACT 26-11-2012.pdf 2012-11-26
51 Description_Granted 302326_22-10-2018.pdf 2018-10-22
52 4068-CHE-2011 CLAIMS 26-11-2012.pdf 2012-11-26
52 Claims_Granted 302326_22-10-2018.pdf 2018-10-22
53 4068-CHE-2011 DESCRIPTION (COMPLETE) 26-11-2012.pdf 2012-11-26
53 Abstract_Granted 302326_22-10-2018.pdf 2018-10-22
54 4068-CHE-2011 FORM-1 26-11-2012.pdf 2012-11-26
54 4068-CHE-2011-PatentCertificate22-10-2018.pdf 2018-10-22
55 4068-CHE-2011 FORM-2 26-11-2012.pdf 2012-11-26
55 4068-CHE-2011-IntimationOfGrant22-10-2018.pdf 2018-10-22
56 4068-CHE-2011 FORM-3 26-11-2012.pdf 2012-11-26
56 4068-CHE-2011-FORM 13 [16-11-2018(online)].pdf 2018-11-16
57 4068-CHE-2011 FORM-5 26-11-2012.pdf 2012-11-26
57 Correspondence by Applicant_Form-13_26-11-2018.pdf 2018-11-26
58 4068-CHE-2011-RELEVANT DOCUMENTS [27-03-2019(online)].pdf 2019-03-27
58 4068-CHE-2011 CORRESPONDENCE OTHERS 26-11-2012.pdf 2012-11-26
59 4068-CHE-2011-FORM FOR SMALL ENTITY [31-10-2019(online)].pdf 2019-10-31
59 4068-CHE-2011 CORRESPONDENCE OTHERS 26-11-2012.pdf 2012-11-26
60 4068-CHE-2011-EVIDENCE FOR REGISTRATION UNDER SSI [31-10-2019(online)].pdf 2019-10-31
60 4068-CHE-2011 FORM-13 26-11-2012.pdf 2012-11-26
61 Correspondence by Agent_Form28_14-11-2019.pdf 2019-11-14
61 4068-CHE-2011 DESCRIPTION (PROVISIONAL) 25-11-2011.pdf 2011-11-25
62 4068-CHE-2011 FORM-1 25-11-2011.pdf 2011-11-25
62 4068-CHE-2011-RELEVANT DOCUMENTS [22-02-2020(online)].pdf 2020-02-22
63 4068-CHE-2011 FORM-2 25-11-2011.pdf 2011-11-25
63 4068-CHE-2011-Form 27_License_04-03-2020.pdf 2020-03-04
64 4068-CHE-2011 FORM-3 25-11-2011.pdf 2011-11-25
64 4068-CHE-2011-Correspondence_15-02-2021.pdf 2021-02-15
65 4068-CHE-2011 FORM-5 25-11-2011.pdf 2011-11-25
65 4068-CHE-2011-RELEVANT DOCUMENTS [18-08-2021(online)].pdf 2021-08-18

Search Strategy

1 4068-CHE-2011SR_24-10-2017.pdf

ERegister / Renewals

3rd: 20 Nov 2018

From 25/11/2013 - To 25/11/2014

4th: 20 Nov 2018

From 25/11/2014 - To 25/11/2015

5th: 20 Nov 2018

From 25/11/2015 - To 25/11/2016

6th: 20 Nov 2018

From 25/11/2016 - To 25/11/2017

7th: 20 Nov 2018

From 25/11/2017 - To 25/11/2018

8th: 20 Nov 2018

From 25/11/2018 - To 25/11/2019

9th: 31 Oct 2019

From 25/11/2019 - To 25/11/2020

10th: 23 Nov 2020

From 25/11/2020 - To 25/11/2021